A leading biosciences company used AttackIQ to demonstrate the effectiveness of its security controls to cyberinsurance providers, addressing increasingly complex underwriting requirements. By generating evidence through simulated attacks on critical systems, the company successfully validated its defenses, retained coverage, and reduced insurance premiums—saving millions. AttackIQ also enabled the small security team to operate without a dedicated red team, accelerating program maturity and supporting board-level reporting with data-driven insights. For the business, this translated into cost savings, stronger governance, improved investor confidence, and a scalable approach to cybersecurity validation.

Join for free to read